-
Product Insights
NewDengue Fever – Drugs In Development, 2024
Empower your strategies with our Dengue Fever – Drugs In Development, 2024 report and make more profitable business decisions. Dengue is a mosquito-borne infectious disease caused by the dengue virus. Symptoms include a high fever, headaches, joint and muscle pain, vomiting, and a rash. In some cases, dengue turns into dengue hemorrhagic fever, which causes bleeding from the nose, gums, or under the skin. It can also become dengue shock syndrome, which causes massive bleeding and shock. Treatment includes use of...
-
Product Insights
NewZika Virus Infections – Drugs In Development, 2024
Empower your strategies with our Zika Virus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Zika virus infection is caused by a virus transmitted primarily by Aedes mosquitoes. Zika virus is a member of the Flaviviridae family. Symptoms include fever, skin rashes, conjunctivitis, muscle and joint pain, malaise, and headache. Risk factors include being in tropical and subtropical areas. Zika virus can also be transmitted through sexual intercourse. Treatment is aimed at relieving symptoms (joint pain...
-
Product Insights
NewMycoses – Drugs In Development, 2024
Empower your strategies with our Mycoses – Drugs In Development, 2024 report and make more profitable business decisions. Mycoses, also known as fungal infections, encompass a diverse group of diseases caused by fungi. These infections can affect various tissues in the body, including the skin, nails, and internal organs. Superficial mycoses, like athlete's foot and ringworm, involve the outer layers, while systemic mycoses can affect deeper tissues and may be more severe, particularly in individuals with weakened immune systems. Candidiasis is...
-
Product Insights
NewRespiratory Syncytial Virus (RSV) Infections – Drugs In Development, 2024
Empower your strategies with our Respiratory Syncytial Virus (RSV) Infections – Drugs In Development, 2024 report and make more profitable business decisions. Respiratory syncytial virus (RSV) infection is a respiratory disease. RSV commonly causes bronchiolitis (inflammation of the small airways in the lung) and pneumonia in children less than one year of age. The symptoms of RSV infection include cough, stuffy or runny nose, mild sore throat, earache, and fever. Treatment includes proper medication and hygiene practice. The Respiratory Syncytial Virus...
-
Product Insights
NewMalaria – Drugs In Development, 2024
Empower your strategies with our Malaria – Drugs In Development, 2024 report and make more profitable business decisions. Malaria is a life-threatening blood disease caused by a parasite (Plasmodium) that is transmitted to humans by the Anopheles mosquito. People at increased risk of serious disease include young children and infants, travelers coming from areas with no malaria, and pregnant women and their unborn children. Symptoms may include fever, chills, headache, sweats, fatigue, enlarged spleen, nausea, and vomiting. Treatment includes anti-malarial medicines....
-
Product Insights
NewMycobacterium tuberculosis Infections – Drugs In Development, 2024
Empower your strategies with our Mycobacterium tuberculosis Infections – Drugs In Development, 2024 report and make more profitable business decisions. The group of infections caused by Mycobacterium tuberculosis (M. tuberculosis) are referred to as Mycobacterium tuberculosis infections, which primarily affect the lungs but can also impact other parts of the body. The symptoms include persistent cough, fever, weight loss, and night sweats. Treatment typically involves a combination of antibiotics taken over several months. M. tuberculosis infections remain a significant global health...
-
Product Insights
NewTuberculosis – Drugs In Development, 2024
Empower your strategies with our Tuberculosis – Drugs In Development, 2024 report and make more profitable business decisions. Tuberculosis, commonly known as TB, is a bacterial infection that can spread through the lymph nodes and bloodstream to any organ in body. It is most often found in the lungs. The symptoms of tuberculosis range from no symptoms (latent tuberculosis) to symptoms of active disease. Symptoms include overall sensation of feeling unwell; cough, possibly with bloody mucus; fatigue; shortness of breath; weight...
-
Report Bundle
54% offTech in Food Service – Report Bundle (7 Reports)
“Technology and innovation have helped the foodservice sector by changing how we look at the guest service experience. Staying connected and engaged with their customers not only helped restaurants transform and survive but also expand. Everything from online orders to self-checkout, from contactless payment methods to deliveries, the restaurant industry integrated the latest trends set in the food industry to remain relevant and competitive.” As a part of this bundle, you will gain access to in-depth insights available in the...
-
Thematic Analysis
Cybersecurity in Foodservice – Thematic Research
The global cybersecurity revenue in foodservice was $1.2 billion in 2020. The market is expected to grow at a CAGR of more than 11% during the forecast period. The COVID-19 pandemic forced foodservice companies to digitally transform, shifting to online delivery, remote communication with employees, and digitalizing supply chain management. Foodservice suppliers that neglect the cybersecurity of operational technology (OT) are at risk of increasingly frequent and complex ransomware attacks, as evidenced by JBS’ ransomware attack in 2021. The growth...
-
Sector Analysis
Mass Affluent Target Propositions, 2021 Update – A Key for Sustainability and Growth
The global wealth market will increase by 8% in 2021. Targeting the mass affluent demographic has worked its way up the priority list for banks and wealth managers in recent years. Some banks are not new to capturing this demographic with dedicated services, but in this digital transformation period competition for this lucrative group is on the rise. Heightened competition and regulatory costs for wealth managers, low interest rate margins for banks, and new digital entrants keen to keep their...